menu
    • menu

    Company profile for Locus Biosciences

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Locus Biosciences is a biotechnology company that develops CRISPR-engineered precision antibacterial products. Our CRISPR-Phage (“crPhage”) platform combines the antibacterial power of CRISPR-Cas3 with the efficient, safe delivery of bacterial viruses called bacteriophage. By selectively removing unwanted bacteria while leaving the many species of good bacteria intact, crPhage™ can address the growing set of diseases sho...
    Locus Biosciences is a biotechnology company that develops CRISPR-engineered precision antibacterial products. Our CRISPR-Phage (“crPhage”) platform combines the antibacterial power of CRISPR-Cas3 with the efficient, safe delivery of bacterial viruses called bacteriophage. By selectively removing unwanted bacteria while leaving the many species of good bacteria intact, crPhage™ can address the growing set of diseases shown to be related to the human microbiome. Locus Biosciences’ high-throughput discovery automation platform and powerful synthetic biology methods enable rapid and modular drug product development against any target.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Locus BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    523 Davis Drive Suite 350 Morrisville NC 27560
    Telephone
    Telephone
    +1-(919) 495-4510
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.locus-bio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/locus-biosciences-inc./
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/LocusBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Locus Bio Gets $3.3M NIH Funding For AI-Designed Phage Therapy
    Locus Bio Gets $3.3M NIH Funding For AI-Designed Phage Therapy

    07 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260107087047/en/Locus-Biosciences-Awarded-%243.3-Million-from-NIH-to-Support-Clinical-Trial-of-AI-Designed-Bacteriophage-Therapy-for-Pneumonia-caused-by-Antibiotic-Resistant-Bacteria

    BUSINESSWIRE
    07 Jan 2026
    Share Share
    Locus Bio In Research Collab For Precision Antibacterial Therapy
    Locus Bio In Research Collab For Precision Antibacterial Therapy

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028884212/en/Locus-Biosciences-Enters-Research-Collaboration-to-Develop-Precision-Antibacterial-Therapies-for-Ophthalmic-Infections

    BUSINESSWIRE
    28 Oct 2025
    Share Share
    Locus Biosciences Announces Positive Phase 2 Results In The Lancet
    Locus Biosciences Announces Positive Phase 2 Results In The Lancet

    12 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/12/2928291/0/en/Locus-Biosciences-Announces-Positive-Results-from-Part-1-of-ELIMINATE-Phase-2-Trial-of-the-Engineered-Bacteriophage-Therapy-LBP-EC01-Published-in-The-Lancet-Infectious-Diseases.html

    GLOBENEWSWIRE
    12 Aug 2024
    Share Share
    Locus Biosciences Announces $23.9 Million in Funding from BARDA
    Locus Biosciences Announces $23.9 Million in Funding from BARDA

    23 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/23/2813976/0/en/Locus-Biosciences-Announces-23-9-Million-in-Funding-from-BARDA-to-Support-First-Phase-2-Trial-of-CRISPR-engineered-Bacteriophage-Therapy.html

    GLOBENEWSWIRE
    23 Jan 2024
    Share Share
    Locus Announces First Patient Treated in the ELIMINATE Ph2/3 Trial of LBP-EC01
    Locus Announces First Patient Treated in the ELIMINATE Ph2/3 Trial of LBP-EC01

    13 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/13/2514936/0/en/Locus-Biosciences-Announces-First-Patient-Treated-in-the-ELIMINATE-Registrational-Phase-2-3-Trial-of-LBP-EC01-for-Urinary-Tract-Infections.html

    GLOBENEWSWIRE
    13 Sep 2022
    Share Share
    Locus closes $35M financing, zeros in on antibiotic resistance
    Locus closes $35M financing, zeros in on antibiotic resistance

    19 May 2022

    // Gabrielle Masson FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/jj-backed-locus-closes-35m-financing-crispr-based-antimicrobial-drugs

    Gabrielle Masson FIERCEBIOTECH
    19 May 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search